United Therapeutics Stock
Price
Target price
€259.70
€259.70
-0.270%
-0.7
-0.270%
€369.12
09:31 / Tradegate
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
United Therapeutics Stock
The price for the United Therapeutics stock decreased slightly today. Compared to yesterday there is a change of -€0.700 (-0.270%).
With 25 Buy predictions and 1 Sell predictions United Therapeutics is one of the favorites of our community.
With a target price of 369 € there is a positive potential of 42.09% for United Therapeutics compared to the current price of 259.7 €.
So far the community has only identified positive things for United Therapeutics stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of United Therapeutics in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | -0.270% | 1.481% | 4.202% | -14.930% | -23.636% | 17.881% | 163.030% |
| Ironwood Pharmaceuticals | -5.480% | 12.698% | 17.355% | -88.640% | -83.095% | -93.810% | -91.497% |
| Novocure Ltd | 3.090% | -23.649% | -27.068% | -38.466% | -63.359% | -84.783% | -81.469% |
| Iovance Biotherapeutics Inc. | 14.840% | 37.208% | 73.453% | -66.912% | -59.658% | -75.900% | -88.358% |
Comments
United Therapeutics Corporation (NASDAQ: UTHR) had its price target lowered by analysts at JPMorgan Chase & Co. from $350.00 to $330.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Corporation (NASDAQ: UTHR) had its price target lowered by analysts at UBS Group AG from $410.00 to $385.00. They now have a "buy" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $405.00 price target on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
